RECOMMENDATION ON THE TREATMENT OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS AT A BRAZILIAN PUBLIC ONCOLOGICAL INSTITUTION: EDUCATIONAL PLAN C Rothschild; NL Nedachi; AP Rabelo; PR Souza; GBG Faria; MR Silva; AAGS Brandão; MDPE Diz; J Pereira; V Rocha;

PHARMACEUTICAL VIGILANCE AND EDUCATION: THE FIRST 6 MONTHS OF A NEW ANTICOAGULANT AT A BRAZILIAN PUBLIC CANCER INSTITUTE C Rothschild; AH Sabanai; AAD Santos; CO Sousa; RS Siqueira; TRVF Neves; AAGS Brandão; MDPE Diz; J Pereira; V Rocha;

OUTCOMES AND TOXICITY PROFILE IN ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS (DLBCL): A REAL-WORLD AND COMPARATIVE STUDY INVOLVING THREE DIFFERENT DOSE-MODULATED ANTHRACYCLINE-BASED IMMUNOCHEMOTHERAPY REGIMENS IN LATAM LAPC Lage; RN Vita; CO Reichert; HF Culler; FA Freitas; LBO Alves; V Rocha; SAC Siqueira; RO Costa; J Pereira;